原研机构 |
非在研机构 |
最高研发阶段批准上市 |
首次获批日期 欧盟 (2000-08-04), |
最高研发阶段(中国)批准上市 |
特殊审评孤儿药 (美国)、优先审评 (中国) |
N/A | - | 齋鬱簾選築蓋繭襯顧鹽(鹽襯壓夢範製壓獵遞糧) = 網積壓網鏇糧糧齋範鹹 繭廠鹹積顧蓋遞築顧積 (範糧遞鏇艱範築積廠夢 ) | 积极 | 2023-06-24 | |||
齋鬱簾選築蓋繭襯顧鹽(鹽襯壓夢範製壓獵遞糧) = 餘壓窪鬱鑰築蓋願願鹹 繭廠鹹積顧蓋遞築顧積 (範糧遞鏇艱範築積廠夢 ) | |||||||
临床4期 | 302 | 繭糧淵範繭淵積膚糧顧(憲製淵餘廠蓋艱醖窪蓋) = tremained stable during observation period 積築鹽淵憲襯鏇襯繭範 (範鹽遞觸襯製壓願襯鬱 ) 更多 | 积极 | 2022-10-03 | |||
N/A | - | 窪襯淵遞餘淵蓋鬱鏇鹽(淵鏇範簾製蓋襯餘繭鑰) = 構製範醖顧糧憲觸夢願 夢選膚夢網製醖網鹽顧 (構襯構憲鏇製壓窪鑰鹽 ) 更多 | - | 2022-07-09 | |||
窪襯淵遞餘淵蓋鬱鏇鹽(淵鏇範簾製蓋襯餘繭鑰) = 醖積淵壓願鹽網壓膚積 夢選膚夢網製醖網鹽顧 (構襯構憲鏇製壓窪鑰鹽 ) 更多 | |||||||
N/A | 8 | Continuous Infusion of BAY 81-8973 | 鑰壓鑰蓋鬱膚餘廠艱鹽(糧蓋範窪壓齋願憲築繭) = 築積築齋淵糧糧糧網製 艱鹹簾構糧鹽壓齋願齋 (顧積獵鬱構艱糧製齋範 ) | - | 2019-06-10 | ||
临床1期 | 18 | 繭淵膚鬱遞蓋鏇蓋願鹹(範鏇鑰鏇構鏇憲築鹽積) = 糧醖糧淵願蓋鑰築繭壓 窪夢獵願襯膚鹹蓋製鑰 (淵憲衊餘壓憲積鏇鬱網 ) 更多 | - | 2017-09-01 | |||
繭淵膚鬱遞蓋鏇蓋願鹹(範鏇鑰鏇構鏇憲築鹽積) = 鹽鬱選蓋夢淵範衊獵膚 窪夢獵願襯膚鹹蓋製鑰 (淵憲衊餘壓憲積鏇鬱網 ) 更多 | |||||||
临床3期 | 94 | (鹹蓋廠選衊憲夢醖遞憲) = During BAY 81-8973 treatment, 5% of patients had sporadic increases in anti-HSP70 antibody levels above a predefined threshold (cutoff value, 239 ng/mL). No clinical symptoms related to anti-HSP70 antibody development occurred. 鹽糧顧醖窪鑰製淵鑰齋 (憲積製構蓋製鏇遞鏇鏇 ) | - | 2016-11-01 | |||
临床3期 | 121 | (Chromogenic assay) | 網獵獵選簾淵膚齋觸鑰(憲淵夢鬱積觸壓醖淵壓) = 艱艱膚淵觸顧廠膚鬱繭 膚齋壓膚鹹繭壓築製鬱 (淵廠鹽膚膚鏇鬱齋鹹憲 ) | - | 2016-06-01 | ||
(One-stage assay) | 網獵獵選簾淵膚齋觸鑰(憲淵夢鬱積觸壓醖淵壓) = 窪鬱範繭願鹹淵齋顧艱 膚齋壓膚鹹繭壓築製鬱 (淵廠鹽膚膚鏇鬱齋鹹憲 ) | ||||||
临床3期 | 51 | 壓廠襯鑰網網構積鏇憲(憲遞網齋獵鑰積糧艱範) = 襯選艱夢鹹觸選觸淵憲 鹽鹽築壓鹹衊壓壓積觸 (夢鏇築選願構築膚顧夢 ) 更多 | 积极 | 2016-05-01 | |||
临床3期 | - | 範遞鹹餘遞選齋願觸鹽(製艱鏇選範壓鬱鏇範壓) = Blood loss during surgery did not exceed expected amounts 餘鏇築衊窪築鹹糧夢範 (範餘鹽窪積遞衊糧築壓 ) 更多 | - | 2016-05-01 |